FEB 02, 2016 09:00 AM PST

Arrays or RNA-Seq? Choosing the right tool for the job

SPONSORED BY: Affymetrix, Affymetrix
Speakers
  • Research Associate Professor, Biomedical Sciences, Director, Microarray and NextGen Sequencing Core, Center for Functional Genomics, SUNY Albany
    Biography
      Dr. Sridar Chittur received a Bachelor's degree in Pharmacy from Bombay University (India), a Ph.D. in Medicinal Chemistry from West Virginia University and an M.B.A in New Venture Development from the University at Albany. He did his post-doctoral training in Enzymology/Pharmacology at the Purdue University School of Pharmacy, following which he briefly worked at Myomatrix Therapeutics LLC. He is currently a Research Associate Professor in the Department of Biomedical Sciences at the University at Albany's School of Public Health. He also directs the Microarray and High Throughput DNA Sequencing Core at the Center for Functional Genomics. His research interests include epigenetics, high throughput screening technologies and drug discovery. He is also an active member of the Association of Biomolecular Facilities (ABRF) and serves on various ABRF Research Groups that focus on studies of nucleic acids, genomics and flow cytometry.
    • Assistant Research Professor, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine
      Biography
        Dr. Yesim Gökmen-Polar is an Assistant Research Professor in the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine. Her research interests are centered on the identification of novel therapeutic targets in breast and thymic cancers resistant to standard of care therapy. She has approximately 50 publications mainly in the field of cancer biology. Her specific expertise is in development of novel therapeutic targets (i.e. targeting EphA2 receptor tyrosine kinase, protein kinase C beta, anti-tubulins and TORC1/2) in colon, breast cancer and thymic malignancies. Her lab developed and characterized a novel human thymoma model, designated as IU-TAB-1, which was derived from a patient with the stage II thymoma (WHO type A/B). Dr. Gökmen-Polar's current research uses next generation sequencing (NGS), next generation microarrays such as Clariom D Human Transcriptome Analysis, and preclinical models to understand the transcriptional regulation/mechanisms of resistance and develop novel targeted therapies. The ultimate goal of her research is to prevent development of recurrences and improve the quality of life for patients.

      Abstract:
      DATE: February 2nd, 2016
      TIME:  9am pacific time, 12pm eastern time


      What is the most appropriate technology to empower your research?
       
      Next generation sequencing (NGS) for RNA (RNA-Seq) has advanced significantly over the last decade having gained popularity for investigating a wide variety of complex diseases at the transcriptome level. While RNA-Seq is an appropriate technology for de novo discovery, it has significant limitations particularly for detecting low abundance transcripts and alternative splicing events, both of which require very deep sequencing. Increasing sequencing depth can result in dramatically increased costs and the requirement for considerable expertise in bioinformatics to effectively analyze data. The scientific community now widely acknowledges that there are specific applications best served by arrays and others by RNA-Seq. Additionally, many see an opportunity to harness the power of both technologies for expression studies.
       
      During this webinar, the speakers will:
      • Discuss the pros and cons of each technology along with platform application suitability
      • Demonstrate how arrays and RNA-Seq can be used to complement each other
      • Explain how recently developed next generation arrays from Affymetrix can be used to overcome the limitations of RNA-Seq in both research and clinical settings
      • Answer your questions live during the broadcast!

      Show Resources
      You May Also Like
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      MAY 03, 2018 11:00 AM PDT
      MAY 03, 2018 11:00 AM PDT
      DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
      MAY 24, 2018 09:30 AM PDT
      C.E. CREDITS
      MAY 24, 2018 09:30 AM PDT
      DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
      AUG 16, 2018 08:00 AM PDT
      C.E. CREDITS
      AUG 16, 2018 08:00 AM PDT
      DATE: August, 16, 2018TIME: 08:00AM PDTThis webinar will review recent advancements in the application of next-generation sequencing of T cell receptor beta (TCRB) chain repertoires towards...
      JUN 26, 2018 06:00 AM PDT
      C.E. CREDITS
      JUN 26, 2018 06:00 AM PDT
      Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
      SEP 12, 2017 08:00 AM PDT
      SEP 12, 2017 08:00 AM PDT
      DATE: September 12, 2017TIME: 8:00am PT, 11:00am ETEvery year, millions of dollars are wasted on poorly characterized and performing antibodies.  Key researchers in the antibody co...
      Loading Comments...
      Show Resources